IL17A and non-melanoma skin carcinoma: IL17 signaling plays a pivotal role in many autoimmune diseases (e.g., psoriasis, inflammatory bowel diseases, and spondyloarthropathies) as defense against pathogen insults (e.g., Candida, Cryptococcus, Klebsiella, and Staphylococcus) and human malignancies (e.g., prostate cancer, cervical cancer, esophageal cancer, gastric cancer, hepatocellular carcinoma, lung cancer, non-melanoma skin cancer, and colorectal cancer) [1,21,24,37,38,39,40].